Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Buchmann, R.
Right arrow Articles by Lange, D.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchmann, R.
Right arrow Articles by Lange, D.E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Amplified Crevicular Leukocyte Activity in Aggressive Periodontal Disease

R. Buchmann1,*, A. Hasilik2, T.E. Van Dyke1 and D.E. Lange3

1 Department of Periodontology and Oral Biology, Goldman School of Dental Medicine, Boston University, Boston, MA, USA;
2 Institute of Physiological Chemistry, University of Marburg, Germany; and
3 Department of Periodontology, School of Dental Medicine, University of Münster, Germany;


Figure F
View larger version (19K):
[in this window]
[in a new window]

  		Figure. Initial GCF neutrophil responses in AP were significantly amplified compared with those in CP. (A) Myeloperoxidase activity (MPO); (B) beta-N-acetyl-hexosaminidase activity (Beta-NAH); (C) cathepsin D (CD); and (D) elastase-alpha-1-proteinase inhibitor complex (Alpha-1-EPI). PRE = outset. 6 M = 6 mos post-therapy. The post-treatment levels remained significantly different between AP and CP (not CD and Alpha-1-EPI).

 

Journal of Dental Research, Vol. 81, No. 10, 716-721 (2002)
DOI: 10.1177/154405910208101012
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?